Phase I clinical trial - Phases précoces tumeurs solides

EMBER (J2J-MC-JZLA)
Phases précoces tumeurs solides
Ouvert depuis le: 09.17.2021
Site: Paris
Public cible
Adulte
EMBER: A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination With Anticancer Therapies for Patients With ER+ Locally Advanced or Metastatic Breast Cancer and Other Select Non-Breast Cancers.
Description de l'essai

The reason for this study is to see if the study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer or endometrial cancer.